Neoadjuvant mitoxantrone and docetaxel for high-risk localized prostate cancer

Mark Garzotto1,2, Anne Myrthue3, Celestia S. Higano4, Tomasz M. Beer3
1Urology Section, Surgical Service, Portland VA Medical Center, Portland, OR 97239, USA
2Division of Urology and Renal Transplantation, Oregon Health & Science University, Portland, OR 97239, USA
3Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR 97239, USA
4Divisions of Urology and Oncology, University of Washington, Seattle, WA 98109, USA

Tài liệu tham khảo